CBL - Trademark Details
Status: 710 - Cancelled - Section 8
Serial Number
85390442
Registration Number
4333516
Word Mark
CBL
Status
710 - Cancelled - Section 8
Status Date
2019-12-20
Filing Date
2011-08-05
Registration Number
4333516
Registration Date
2013-05-14
Mark Drawing
4000 - Standard character mark
Typeset
Published for Opposition Date
2013-02-26
Attorney Name
Law Office Assigned Location Code
M60
Employee Name
COWARD, KATHRYN E
Statements
Goods and Services
Active chemical ingredients and excipients for use in the manufacture of pharmaceuticals consisting of compounds that facilitate delivery of a wide range of pharmaceuticals for pharmaceutical actives
Goods and Services
Analgesic and muscle relaxant pharmaceutical preparations; Anti-diabetic pharmaceuticals; Antibacterial pharmaceuticals; Cardiovascular pharmaceuticals; Cellulose esters for pharmaceutical purposes; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of a coating for tablets that facilitate the delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical antitussive-cold preparations; Pharmaceutical preparation for skin care; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for treating allergies; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical preparations, namely, an analgesic for human consumption taken orally; Pharmaceutical preparations, namely, anticoagulants; Pharmaceutical preparations, namely, antidepressants; Pharmaceutical preparations, namely, appetite suppressants; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for the treatment of joint disease; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthma; Pharmaceuticals, namely, lipid lowering agents
Classification Information
International Class
001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins, unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins, unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes
001, 005, 006, 010, 026, 046
Class Status Code
2 - Sec. 8 - Entire Registration
Class Status Date
2019-12-20
Primary Code
001
First Use Anywhere Date
2011-03-20
First Use In Commerce Date
2011-03-20
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
2 - Sec. 8 - Entire Registration
Class Status Date
2019-12-20
Primary Code
005
First Use Anywhere Date
2011-03-20
First Use In Commerce Date
2011-03-20
Correspondences
Name
CRAIG M. BELL
Address
Please log in with your Justia account to see this address.
Trademark Events
| Event Date | Event Description |
| 2011-08-09 | NEW APPLICATION ENTERED IN TRAM |
| 2011-08-10 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| 2011-08-11 | NOTICE OF PSEUDO MARK MAILED |
| 2011-11-30 | ASSIGNED TO EXAMINER |
| 2011-12-12 | NON-FINAL ACTION WRITTEN |
| 2011-12-12 | NON-FINAL ACTION E-MAILED |
| 2011-12-12 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 2012-06-05 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 2012-06-05 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 2012-06-06 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 2012-07-03 | ASSIGNED TO EXAMINER |
| 2012-08-13 | NON-FINAL ACTION WRITTEN |
| 2012-08-13 | NON-FINAL ACTION E-MAILED |
| 2012-08-13 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 2012-12-11 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 2012-12-11 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 2012-12-11 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 2013-01-08 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 2013-01-23 | ASSIGNED TO LIE |
| 2013-01-23 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| 2013-02-06 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 2013-02-26 | PUBLISHED FOR OPPOSITION |
| 2013-02-26 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 2013-05-14 | REGISTERED-PRINCIPAL REGISTER |
| 2018-05-14 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| 2019-12-20 | CANCELLED SEC. 8 (6-YR) |
